IDO1 and neoplasm: Preclinical studies demonstrated that IFN-γ resulting IDO1/aryl hydrocarbon receptor (AhR) dependent p27 induction could prevent STAT1 signaling, thus suppressing the process of tumor cell death and activating tumor dormancy program (19).